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Erika Bertella, MD,* Sarah Cortinovis, MD,* Saima Mushtaq, MD,* Claudia Foti, MS,*
Andrea Annoni, MD,* Alberto Formenti, MD,* Andrea Baggiano, MD,*
Edoardo Conte, MD,* Francesca Bovis, MS,* Fabrizio Veglia, MS,* Giovanni Ballerini, MD,*
Cesare Fiorentini, MD,*y Piergiuseppe Agostoni, MD,*y Mauro Pepi, MD*
Milan, ItalyOBJECTIVES The aim of the study was to perform a comparison of the prognostic performance of
computed tomography coronary angiography (CTA) and exercise electrocardiography (ex-ECG) in pa-
tients with suspected coronary artery disease (CAD).
BACKGROUND CAD is a major cause of mortality and morbidity, and its management consumes a
large proportion of the health care budget. Therefore, identiﬁcation of patients at high risk of adverse
events is crucial. Despite its limited accuracy, ex-ECG is the most commonly used noninvasive test in
CAD evaluation. CTA was recently introduced as alternative test.
METHODS We enrolled 681 patients (age 61.3  10.4 years, 461 men) with atypical or typical angina
and no history of CAD. All patients underwent ex-ECG and CTA and were followed for 44 12 months.
The endpoints were all cardiac events, deﬁned as nonfatal myocardial infarction, cardiac death, and
revascularization, and hard cardiac events, deﬁned as all cardiac events excluding revascularization.
RESULTS ex-ECG and CTA were rated as positive in 419 (61%) and 274 (40%) of 681 patients, respec-
tively. In univariate analysis, both ex-ECG and CTA were predictors of all cardiac events (hazard ratio [HR]:
2.09, 95% conﬁdence interval [CI]: 1.5 to 2.8; p < 0.0001 and HR: 21.1, 95% CI: 14.6 to 30.5; p < 0.0001,
respectively) and hard cardiac events (HR: 1.9, 95% CI: 1.1 to 3.2; p ¼ 0.02 and HR: 6.8, 95% CI: 3.9 to 11.0;
p < 0.0001, respectively), whereas in a multivariate analysis, CAD with $50% stenoses detected by
CTA was the only independent predictor of hard cardiac events. Stratifying our population by ex-ECG
and CTA ﬁndings, Kaplan-Meier curves showed that ex-ECG provides only a further risk stratiﬁcation in
the subset of patients with positive ﬁndings on CTA and a low to intermediate likelihood of CAD. More-
over, positive ﬁndings on CTA identify a shorter event-free period, regardless the ex-ECG ﬁndings for
both all cardiac events and hard cardiac events, respectively.
CONCLUSIONS CTA may have a higher prognostic value compared with ex-ECG in patients with
suspected CAD, mainly in those with a low to intermediate pre-test likelihood of CAD. (J Am Coll Cardiol
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A N D A C R O N YM S
CAD = coronary artery dise
CI = conﬁdence interval
CTA = computed tomogra
coronary angiography
ex-ECG = exercise
electrocardiography
HR = hazard ratio
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642oronary artery disease (CAD) is a major
cause of mortality and morbidity, and its
management consumes a large proportion
of the health care budget. Therefore, iden-
tiﬁcation of patients at high risk of adverse events is
crucial. Exercise electrocardiography (ex-ECG) is
the most commonly used noninvasive test for the
diagnosis of CAD. However, ex-ECG stress has
poor sensitivity and speciﬁcity (1). Indeed, ex-ECG
may detect ischemia but not the presence of
atherosclerosis in the absence of a ﬂow-limiting ste-
nosis. Computed tomography coronary angiography
(CTA) was recently introduced as an anatomic im-
aging method for the evaluation of CAD. Several
studies support the use of CTA to rule out the
presence of CAD with high accuracy (2,3) and also
for improving prognostic assessment above baseline
risk factor evaluation (4–10). Retrospective
comparative studies showed that CTA has a higher
diagnostic accuracy compared with ex-ECG for
detecting signiﬁcant CAD (11,12). However, only a
few studies have been conducted to compare thease
phyprognostic value of CTA and ex-ECG on
a mid-term follow-up (13), whereas no
data are available for long-term follow-up.
Therefore, the aim of the study was to
compare the prognostic performance of
CTA and ex-ECG in consecutive patients
referred for suspected CAD with long-
term follow-up.
METHODSStudy population. We identiﬁed 3,750 consecutive
patients referred to our hospital for diagnostic
evaluation of atypical or typical angina between
January 2005 and May 2010. We excluded
from the present analysis patients with known
CAD (n ¼ 1,410) or known nonischemic cardiac
disease (n ¼ 680), pre-existing electrocardio-
graphic changes or inability to perform ex-ECG
with consequent inability to reach the target heart
rate (n ¼ 532), contraindications to contrast agents
(n ¼ 74), impaired renal function deﬁned as
creatinine clearance <60 ml/min (n ¼ 112),
inability to sustain a 15-s breath hold (n ¼ 72),
pregnancy (n ¼ 11), and a resting heart rate $75
beats/min despite beta-blocker treatment or cardiac
arrhythmias (n ¼ 159). The remaining 700 pa-
tients were enrolled in the present study. They
prospectively underwent both ex-ECG and CTA
within 1 week of each other. Both tests were per-
formed in addition to a standard clinical workup
that was based on clinical evaluation and functionalimaging stress test other than ex-ECG. ex-ECG
and CTA ﬁndings were evaluated by different
expert readers blinded to the clinical history of the
patients, and similarly all events recorded during
the follow-up were reviewed by an independent
cardiologist who was blinded to both ex-ECG and
CTA ﬁndings.
Our study complies with the Declaration of
Helsinki. The study was approved by the local ethics
committee. All patients gave written informed
consent.
Clinical history. A structured interview was per-
formed and a clinical history was obtained, and the
following cardiac risk factors were assessed in all
patients before CTA: 1) hypertension (blood pres-
sure >140/90 mm Hg or use of antihypertensive
agents) (14); 2) smoking (currently or previously); 3)
hyperlipidemia (low-density lipoprotein cholesterol
>140 mg/dl) (15); 4) diabetes mellitus (fasting
glucose level >110 mg/dl or the need for insulin
or oral antidiabetes drugs) (16); 5) family history of
CAD in ﬁrst-degree relatives (17); 6) home use
of antianginal drugs; and 7) symptoms (atypical or
typical angina) (18). According to the Diamond
criteria (18), the study population was classiﬁed as
having a pre-test low to intermediate (<70%) or
high (70%) likelihood of CAD.
ex-ECG protocol. Each patient performed a cycle
ergometer-graded exercise test. The stress test
response was considered positive in case of: 1) hori-
zontal or downsloping ST-segment depression >0.1
mV measured at 80 or 60 ms after the J-point during
exercise or recovery; 2) upsloping ST-segment
depression of 0.15 mV at 80 ms after the J-point;
and 3)ST-segment elevation>0.1mVmeasured at 80
or 60 ms after the J-point during exercise or recovery.
CTA protocol and dataset evaluation. CTA was
performed between 1 and 3 days (average, 2.2 
0.4 days) after ex-ECG. In all patients with resting
heart rate >65 beats/min before CTA, metoprolol
was intravenously administered with a titration
dose up to 15 mg to achieve a target heart rate
#65 beats/min.
CTA was performed with a 64-slice scanner
(GE Healthcare, Milwaukee, Wisconsin). Retro-
spective electrocardiographic triggering with elec-
trocardiographic pulsing technique was used before
September 1, 2007, whereas prospective electrocar-
diographic triggering (SnapShot Pulse, GE
Healthcare) was used in patients who were enrolled
after September 1, 2007, and in whom a heart rate
#65 beats/min was reached.
Image CTA datasets were transferred to a dedi-
cated workstation and analyzed with cardiac software
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643(Advantage Workstation and CardioQ3 Package,
GE Healthcare) by 2 expert readers (G.P. and D.A.)
blinded to the ex-ECG ﬁndings. For any disagree-
ment in data analysis between the 2 readers,
consensus agreement was achieved involving a third
expert reader.
Coronary artery segments were classiﬁed accord-
ing to the 16-segment American Heart Association
classiﬁcation (19), including in our analysis all seg-
ments with a diameter of at least 1.5 mm at their
origin. Each segment was classiﬁed as assessable or
not assessable in the presence of severe artifacts
impairing accurate evaluation. Patients with prox-
imal or mid segment or >3 segments classiﬁed as
not assessable were rated as positive (5). For each
assessable segment, the presence of coronary plaque
was deﬁned as a structure >1 mm2 within and/or
adjacent to the artery lumen (4). Then, each patient
was classiﬁed in a patient-based model as having
CAD <50% (at least 1 segment with a stenosis
<50% but no segment with a stenosis $50%),
CAD $50% (at least 1 segment with a stenosis
$50%) and in a vessel-based model as having left
main coronary artery, 1-, 2-, or 3-vessel disease
using a stenosis threshold $50%. Finally, we
calculated the segment involved score measured as
the sum of coronary segments (minimum ¼ 0,
maximum ¼ 16) showing the presence of plaque
irrespective of stenosis severity and the segment
stenoses score calculated as the sum of each segment
score as deﬁned above (total score ranging from 0 to
48) (20).
Follow-up. Patient follow-up was performed by
checking the medical records or by phone interview
by researchers unaware of the patients’ CTA results.
Events were deﬁned as follows: nonfatal myocardial
infarction (typical chest pain with elevated cardiac
enzyme levels and typical ST-segment changes on
the electrocardiogram) (21), late revascularization
deﬁned as elective revascularization 60 days after
CTA and cardiac death (death caused by acute
myocardial infarction, ventricular arrhythmias, or
refractory heart failure). We deﬁned hard cardiac
events as a combined endpoint of nonfatal
myocardial infarction and cardiac death. All cardiac
events were deﬁned as hard cardiac events plus
revascularization of any sort. In case of multiple
events in a given patient, the ﬁrst event was included
in the analysis.
Statistical analysis. According to CTA and ex-ECG
ﬁndings, the study population was divided in 4
groups: group A (CAD <50% and negative ex-
ECG), group B (CAD<50% and positive ex-ECG),
group C (CAD $50% and negative ex-ECG), andgroup D (CAD $50% and positive ex-ECG). Cat-
egorical baseline characteristics were expressed as
numbers and percentages, whereas continuous vari-
ables were expressed as mean  SD. To identify the
association between ex-ECG ﬁndings, CTA vari-
ables, andoutcomes,Cox regression analysis was used.
First, univariate analysis of clinical characteristics
and CTA and ex-ECG ﬁndings was performed to
identify potential predictors. Hazard ratios were
calculated with 95% conﬁdence intervals as an esti-
mate of the risk associated with a particular variable.
To determine independent predictors of the com-
posite endpoints, multivariate analysis of variables
with p # 0.05 in univariate analysis was performed
and corrected for the following baseline characteris-
tics: male sex, age, diabetes, hypercholesterolemia,
hypertension, family history of CAD, and smoking.
Finally, to avoid overﬁtting and multicollinearity is-
sues, we developed a model adjusted for coronary ar-
tery classiﬁcation in 1-, 2-, and 3-vessel disease and
left main coronary artery with CAD$50%.
Cumulative event rates for each group were
obtained with the Kaplan-Meier method for all
cardiac events and hard cardiac events and
compared with the Wilcoxon log-rank test in all
study population and in patients with a low to in-
termediate and high pre-test likelihood of CAD.
Statistical analyses were performed using SPSS
software, version 17.0 (SPSS Inc., Chicago, Illinois)
and the SAS software version 6.12 (SAS Institute
Inc., Cary, North Carolina). A p value <0.05 was
considered signiﬁcant.
RESULTS
The clinical characteristics of the study patients are
given in Table 1. Of 700 patients, 10 were excluded
because a heart rate <75 beats/min was not reached
and 9 patients declined to participate in the follow-
up. Therefore, 681 patients (mean age, 61.3  10.4
years; 461 men) were included in our analysis.
Mean follow-up duration was 44  12 months. A
total of 37 patients (0, 0, 10, and 27 in groups A, B,
C, and D, respectively) underwent early elective
revascularizations and therefore were excluded from
the analysis. During follow-up, all cardiac event and
hard cardiac event endpoints were reached in 251
(37%) and 73 (11%) of patients, with an event-free
survival time of 245  358 days and 608  432
days, respectively.
Based on CTA ﬁndings, 274 (40%) patients had
CAD $50% with a segment involved score and
segment stenoses score of 1.8  2.2 and 4.7  6.6,
respectively. The overall agreement between ex-ECG
Table 1. Characteristics of Study Population and Between-Group Comparison Based on CTA and ex-ECG Findings
All Patients
Group A
CTA L/ex-ECG L
Group B
CTA L/ex-ECG D
Group C
CTA D/ex-ECG L
Group D
CTA D/ex-ECG D
Baseline characteristics
N 681 (100) 183 (27) 224 (33) 79 (12) 195 (28)
Age, yrs 61.3  10.4 59.4  10.2*yk 58.7  10.5zx 63.9  9.3 65.0  9.4
Male 461 (68) 111 (61)* 128 (57)zx 64 (81) 158 (81)
Risk factors
Hypertension 378 (55) 96 (52)*k 92 (41)zx 55 (70) 135 (69)
Smoker 195 (29) 49 (27) 61 (27) 20 (25) 65 (33)
Hyperlipidemia 291 (43) 74 (40)* 71 (32)zx 45 (56) 101 (51)
Diabetes 60 (9) 8 (4)* 12 (5)x{ 10 (13) 30 (15)
Family history of coronary
artery disease
224 (33) 61 (33) 70 (31) 33 (41) 60 (30)
Medical therapy
Beta-blockers 145 (21) 27 (15)* 41 (18)z# 25 (32) 52 (27)
ACE inhibitors 113 (17) 28 (15) 30 (13){ 19 (24) 36 (18)
Aspirin 150 (22) 25 (14)* 26 (12)zx 31 (39) 68 (35)
Nitrates 37 (5) 6 (3)** 4 (2)zx 8 (10) 19 (10)
Statins 170 (24) 32 (17)* 34 (15)zx 35 (44) 69 (35)
Pre-test likelihood of CAD
Low 182 (26) 70 (38) 73 (33)z 21 (27)zz 18 (9)
Intermediate 314 (46) 62 (34)yy 117 (52)z 22 (28)zz 113 (58)
High 185 (27) 51 (28)yy 34 (15)zx 36 (46)xx 64 (33)
CTA characteristics
CAD $50% 274 (40) 0 (0)* 0 (0)z 79 (100) 195 (100)
1 vessel $50% 135 (20) 0 (0)* 0 (0)z 47 (59)xx 88 (45)
2 vessel 50% 91 (13) 0 (0)* 0 (0)z 20 (25) 71 (36)
3 vessel $50% 42 (6) 0 (0)* 0 (0)z 9 (11) 33 (17)
LM $50% 6 (1) 0 (0)* 0 (0)z 3 (4) 3 (2)
Segment involved score 1.8  2.2 0.5  0.9*y 0.5  1.0zx 3.4  2.1xx 4.0  2.1
Segment stenoses score 4.7  6.6 0.5  1.0*y 0.6  1.2zx 9.3  6.1xx 11.2  7.1
ex-ECG positive ﬁndings 419 (61) 0 (0)yyy 224 (100)z 0 (0) 195 (100)
Follow-up
Duration, months 44  12 43  11k** 46  11zx 40  11 42  13
Nonfatal myocardial infarction 62 (9) 7 (4)* 8 (3)zx 13 (17) 34 (18)
Early revascularization 37 (5) 0 (0)*y 0 (0)zx 10 (13) 27 (17)
Late revascularization 178 (26) 5 (3)*y 14 (6)zx 40 (51) 119 (61)
Cardiac death 11 (2) 0 (0) 0 (0)x 0 (0)zz 11 (6)
All cardiac events 251 (37) 12 (7)*y 22 (10)zx 53 (67)zz 164 (81)
All cardiac events free period, days 245  358 644  539*y 742  438zx 140  175 183  300
Hard cardiac events 73 (11) 7 (4)*y 8 (4)zx 13 (16)xx 45 (23)
Hard cardiac events free period, days 608  432 804  393**kk 801  339x{ 403  396 603  445
Values are n (%) or mean  SD. *p < 0.01, group A vs. group C. yp < 0.01, group A vs. group D. zp < 0.01, group B vs. group C. xp < 0.01, group B vs. group D.
kp < 0.05, group A vs. group B. {p < 0.05, group B vs. group C. #p < 0.05, group B vs. group D. **p < 0.05, group A vs. group C. yyp < 0.01, group A vs. group B.
zzp < 0.01, group C vs. group D. xxp < 0.05, group C vs. group D. kkp < 0.05, group A vs. group D.
ACE ¼ angiotensin-converting enzyme; CAD¼ coronary artery disease; CTA¼ computed tomography coronary angiography; ex-ECG¼ exercise electrocardiography;
LM ¼ left main coronary artery.
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Table 2. Univariate and Multivariate Predictors of All Cardiac Events and Hard Cardiac Events
Univariate Analysis Multivariate Analysis
All Cardiac Events Hard Cardiac Events All Cardiac Events Hard Cardiac Events
HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value HR (95% CI) p Value
Baseline
Age 1.0 (1.0–1.1) <0.0001 1.0 (1.0–1.1) 0.035 1.0 (1.0–1.0) 0.006 1.0 (1.0–1.0) 0.606
Male 0.5 (0.3–0.6) <0.0001 0.5 (0.3–0.9) 0.0119 1.2 (0.9–1.7) 0.267 0.9 (0.5–1.8) 0.756
Hypertension 1.6 (1.2–2.1) 0.0005 1.9 (1.1–3.1) 0.014 0.8 (0.6–1.0) 0.07 1.0 (0.5–1.9) 0.916
Smoker 1.2 (0.9–1.6) 0.1267 1.4 (0.9–2.3) 0.1693 NA NA NA NA
Hyperlipidemia 1.7 (1.3–2.2) <0.0001 1.7 (1.1–2.7) 0.0272 1.2 (0.8–1.6) 0.395 0.8 (0.5–1.4) 0.467
Diabetes 1.7 (1.2–2.5) 0.0043 2.1 (1.2–4.0) 0.0162 0.8 (0.5–1.2) 0.208 0.6 (0.2–1.3) 0.177
Family history of coronary
artery disease
1.2 (0.9–1.5) 0.1824 1.2 (0.8–2.0) 0.3614 NA NA NA NA
Medical therapy
Beta-blockers 1.4 (1.1–1.9) 0.0114 0.9 (0.5–1.6) 0.6303 1.1 (0.7–1.5) 0.792 NA NA
ACE inhibitors 1.3 (1.0–1.8) 0.0903 0.7 (0.4–1.4) 0.3247 NA NA NA NA
Aspirin 2.1 (1.6–2.7) <0.0001 1.0 (0.6–1.8) 0.9078 1.0 (0.7–1.5) 0.869 NA NA
Nitrates 1.6 (1.0–2.5) 0.058 1.6 (0.7–3.7) 0.2856 NA NA NA NA
Statins 2.6 (2.0–3.4) <0.0001 1.7 (1.1–2.8) 0.0278 0.8 (0.6–1.2) 0.268 0.9 (0.5–1.6) 0.614
CTA
CAD $50% 21.1 (14.6–30.5) <0.0001 6.8 (3.9–11.0) <0.0001 NA NA NA NA
1 vessel $50% 16.0 (11.5–25.3) <0.0001 4.9 (2.5–9.4) <0.0001 4.4 (2.7–7.1) <0.0001 1.5 (0.7–3.5) 0.332
2 vessel $50% 26.8 (17.7–40.4) <0.0001 8.1 (4.2–15.6) <0.0001 5.2 (3.1–8.7) <0.0001 3.0 (1.0–4.2) 0.022
3 vessel $50% 25.8 (16.0–41.4) <0.0001 9.9 (4.7–20.8) <0.0001 5.2 (2.9–9.3) <0.0001 3.3 (1.2–9.1) 0.014
LM $50% 40.7 (16.9–97.8) <0.0001 11.4 (2.6–50.0) 0.0012 6.4 (2.5–16.6) <0.0002 11.3 (2.0–64.6) 0.007
SSS 1.4 (1.4–1.5) <0.0001 1.4 (1.3–1.5) <0.0001 NA NA NA NA
SSS 1.1 (1.0–1.1) <0.0001 1.1 (1.1–1.1) <0.0001 NA NA NA NA
ex-ECG
Positive 2.09 (1.51–2.78) <0.0001 1.9 (1.1–3.2) 0.0196 0.9 (0.7–1.3) 0.567 0.7 (0.3–1.3) 0.249
CI ¼ conﬁdence interval; HR ¼ hazard ratio; NA ¼ not available; SIS ¼ segment involved score; SSS ¼ segment stenoses score; other abbreviations as in Table 1.
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645and CTA was 55% (378 of 681 patients). Indeed,
CTA and ex-ECG results showed agreement for the
absence 195 (28%) patients (group A) and presence
183 (27%) patients (group D) of signiﬁcant CAD in
and 224 (33%) patients, respectively. In contrast, with
CAD<50% by CTA had positive ex-ECG ﬁndings
(group B) and 79 (12%) patients with CAD 50% had
negative ex-ECG ﬁndings (group C). All cardiac
events and hard cardiac events in groups A, B, C, and
D were, respectively, 12 (7%), 22 (10%), 53 (67%),
and 164 (81%) and 7 (4%), 8 (4%), 13 (16%), and 45
(23%), with an annual rate of 2%, 3%, 20%, and 24%,
and 1%, 1/%, 4%, and 6.3%, respectively. All cardiac
and hard cardiac events had a lower incidence in
groupsA andB versus groups C andD (p< 0.01). Of
note, no difference in terms of events was observed
between groups A and B, whereas group D showed a
higher incidence of all cardiac events (p < 0.01).
Moreover, positive CTA ﬁndings identify a shorterevent-free period versus negative CTA ﬁndings
regardless the ex-ECG ﬁndings for both all cardiac
events (p< 0.01) and hard cardiac events (p< 0.05).
At baseline, the following imaging stress tests
included in the workup decision making such as
stress echocardiography, stress nuclear perfusion
imaging, and stress cardiac magnetic resonance were
performed in 337 (49%), 209 (31%), and 135 (20%)
patients, respectively. These tests were censored as
negative in 313 of 407 patients without CAD on
CTA and positive in 157 of 274 patients with CAD
$50%, with a mean overall agreement signiﬁcantly
higher than the agreement between ex-ECG and
CTA (69% vs. 55%, p < 0.01). The rate of revas-
cularization was higher in patients with abnormal
versus normal imaging stress test ﬁndings (66% vs.
11%, p < 0.01) because these tests were used as a
gatekeeper to invasive coronary angiography and
potential revascularization. Hard cardiac events
Pontone et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 6 , 2 0 1 3
CTA and ex-ECG in Prognostic Stratiﬁcation J U N E 2 0 1 3 : 6 4 1 – 5 0
646occurred in 23 of 430 and in 50 of 251 patients with
normal and abnormal imaging stress test ﬁndings,
respectively, with an annualized hard event rate of
1.4% and 5.4%, respectively (p < 0.001). Of note, in
the subset of patients with normal imaging stress
test results, the annualized hard cardiac event rate
increased from 0.8% to 3% when associated with
negative and positive CTA ﬁndings, respectively
(p ¼ 0.0012).
Table 2 summarizes the univariate and multi-
variate analyses of the clinical characteristics and
CTA and ex-ECG results that were used for event
prediction. In the multivariate analysis, the pres-
ence of CAD $50% on CTA remained the only
independent predictor for all and hard cardiac
events.
Kaplan-Meier curves showed that CTA has a
better prognostic performance compared with
ex-ECG (Fig. 1). From the combined analysis of
ex-ECG and CTA ﬁndings, it was found that CTA
always provided a prognostic stratiﬁcation, whereas
ex-ECG predicted all and hard cardiac events only
in the subset of patients with CAD $50% on CTA
(Fig. 2), particularly in those at high risk in whom a
wrong CAD classiﬁcation on CTA may be possible
(Fig. 3).Figure 1. Kaplan-Meier Survival Curves in Patients Classiﬁed on the
Kaplan-Meier curves for all cardiac events (top) and hard cardiac event
CTA ¼ computed tomography coronary angiography; ex-ECG ¼ exercisDISCUSS ION
The main ﬁndings of this study are the following: 1)
CTA shows a better prognostic performance
compared with ex-ECG; 2) evaluation of coronary
anatomy with CTA may be the ﬁrst diagnostic tool
needed for prognostic stratiﬁcation of patients with a
low to intermediate pre-test likelihood of CAD,
whereas ex-ECGmay bemore appropriate for further
prognostic stratiﬁcation in the subset of patients with
CAD$50% on CTA; and 3) positive CTA ﬁndings
identify a shorter event-free survival time regardless of
the presence of ischemia at ex-ECG.
In the management of patients with suspected
CAD, the prognostic stratiﬁcation plays a crucial role
beyond the simple diagnosis of coronary artery ste-
noses. Indeed, the occurrence of adverse events de-
termines morbidity and mortality and inﬂuences the
overall health expenditure. Until few years ago,
diagnosis and prognostic evaluation of patients with
suspected CAD were made with functional stress
tests only in the majority of patients. Nowadays,
ex-ECG is still regarded as the ﬁrst-line functional
examination in patients with chest pain, and it is the
most widely used test in clinical practice for CAD
assessment and for reﬁning patient prognosis.Basis of ex-ECG and CTA Findings
s (bottom) based on ex-ECG (left) and CTA (right) results.
e electrocardiography.
Figure 2. Kaplan-Meier Survival Curves in Patients Classiﬁed on the Basis of ex-ECG and CTA Findings Combined
Kaplan-Meier curves for all cardiac events (left) and hard cardiac events (right) in patients with negative ex-ECG ﬁndings and coronary artery
disease (CAD) with <50% stenosis (blue line), in patients with positive ex-ECG ﬁndings and CAD with <50% stenosis (red line), in patients
with negative ex-ECG ﬁndings and CAD with $50% stenosis (green line), and in patients with positive ex-ECG ﬁndings and CAD with $50%
stenosis (black line). Abbreviations as in Figure 1.
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647Indeed, ST-segment changes, exercise capacity,
chronotropic response, heart rate recovery, and ven-
tricular ectopy during effort are all well-established
independent risk factors for all-cause cardiovascular
mortality (22). However, the prognostic value of ex-
ECG is challenged by the inability to reﬂect theFigure 3. Kaplan-Meier Survival Curves in Patients Classiﬁed on the
According the Pre-test Likelihood of CAD
Kaplan-Meier curves for all cardiac events (top) and hard cardiac event
<50% stenosis (blue line), in patients with positive ex-ECG ﬁndings and
ﬁndings and CAD with $50% stenosis (green line), and in patients wi
subgroups with low to intermediate (left) and high (right) pre-test likeimpact on prognosis of an atherosclerotic plaque
when it does not impair coronary ﬂow (22). In this
regard, the recent introduction of CTA allows a
noninvasive anatomic evaluation of symptomatic
patients. Robust data regarding its accuracy in the
detection of signiﬁcant CAD have been reported inBasis of ex-ECG and CTA Findings Combined
s (bottom) in patients with negative ex-ECG ﬁndings and CAD with
CAD with <50% stenosis (red line), in patients with negative ex-ECG
th positive ex-ECG and CAD with $50% stenosis (black line) in
lihood of CAD. Abbreviations as in Figures 1 and 2.
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648the literature (2,3). More recently, a potential prog-
nostic role of this diagnostic tool has also emerged
(4–10). Pundziute et al. (5), using CTA, evaluated a
cohort of 104 patients who were followed for 16
months and found that obstructive CAD detection,
the presence of coronary plaques irrespective of ste-
nosis severity, the number of coronary segments with
plaques, and the number of coronary arteries with
mixed plaques were all independent predictors of
cardiac events. This was the ﬁrst report suggesting
that the atherosclerotic burden of coronary arteries
may inﬂuence patient prognosis beyond stenosis
severity. In a later study, Min et al. (4) demonstrated
in a larger cohort of patients that Duke and segment
stenoses scores were signiﬁcant predictors of all-cause
mortality. Regarding the comparison of ex-ECG and
CTA, Dewey et al. (11) showed a higher sensitivity
and speciﬁcity of CTA versus ex-ECG for the
detection of signiﬁcant CAD, whereas in a previous
study,wedemonstrated a complementary role of the 2
tests in patients with equivocal clinical presentation
(12). More recently, Dedic et al. (13) compared the
prognostic performance of ex-ECG with that of
CTA in 424 consecutive patients followed for 2.6
years. Similar to our study, they demonstrated that
the presence of obstructive CAD on CTA showed
incremental value beyond exercise testing in the
prediction of future adverse events. However,
comparedwith our study, the sample size was smaller,
the duration of follow-up was shorter, ex-ECG
ﬁndings were not used for clinical decisions, no data
regarding combined endpoint without revasculari-
zation were reported, and nondiagnostic ex-ECG
results were not excluded from the analysis.
These ﬁndings may be of clinical relevance. First,
the number of vessels with coronary stenoses >50%
is an independent predictor of adverse events. Sec-
ond, ex-ECG retains a prognostic value in patients
with positive CTA ﬁndings. Previous clinical ob-
servations may explain our ﬁndings. Indeed, it has
been shown that adverse events are not due to ﬂow-
limiting coronary stenoses only, the presence of
which is well detected by ex-ECG, but also due to
the atherosclerotic plaque burden, apart from the
degree of coronary ﬂow reduction (23). This sug-
gests that an integrated approach of anatomic and
functional tests may be beneﬁcial when assessing
patients with suspected CAD. In this regard, our
study shows that CTA works well in patients with a
low to intermediate pre-test likelihood of CAD,
whereas its prognostic stratiﬁcation becomes weaker
when the patient’s cardiovascular risk increases. The
reduced performance of CTA in the latter case is
likely due to an increased rate of inaccurateclassiﬁcation of coronary stenoses in high-risk pa-
tients. Indeed, decreased diagnostic accuracy of
CTA with the increase of pre-test likelihood of
CAD was previously reported (3,24). This suggests
that in this patient subset, use of ex-ECG is deﬁ-
nitely needed for further stratiﬁcation. Whether
other functional tests provide better prognostic
stratiﬁcations compared with ex-ECG is beyond the
scope of this study. In this regard, it has been shown
that stress-rest myocardial perfusion imaging is su-
perior to ex-ECG for the detection of myocardial
ischemia and provides independent and incremental
information in predicting future cardiac events (25).
In agreement with these ﬁndings, van Werkhoven
et al. (8) showed that the combined use of CTA and
a nuclear stress test not only provides information
with respect to the presence, extent, and composi-
tion of atherosclerosis, but, more importantly,
improves risk stratiﬁcation compared with myocar-
dial perfusion imaging alone. In our study, despite
that this point is beyond the aim of the study, a
subanalysis of imaging stress tests included in the
diagnostic workup decision making was performed,
conﬁrming that a positive CTA ﬁnding is associated
with a higher rate of hard cardiac events in the
subset of patients without ischemia on imaging
stress tests, as previously demonstrated (8). Further
prospective and blinded studies comparing an in-
tegrated approach using CTA and different func-
tional tests are needed to show which diagnostic
algorithm provides the best prognostic stratiﬁcation.
However, when such a combined strategy that
includes CTA is proposed as a systematic diagnostic
approach, the issues of costs, cumulative radiation
exposure, and nephrotoxicity have to be considered.
First, despite the fact that the cost of CTA is higher
than that of ex-ECG, the evaluation of CAD by
CTA followed by ex-ECG may lower overall health
care costs primarily by decreasing the rate of false-
positive results on ex-ECG. Moreover, due to its
better prognostic value, patients evaluated by CTA
may have fewer CAD-related episodes of care and
consequently lower overall CAD-related costs.
Second, the radiation exposure associated with
CTA is an issue of concern. Although radiation
exposure may differ in relation to different CTA
techniques and protocols, a radiation dose up to
29 mSv may be reached with the ﬁrst generation of
64-slice scanners (26). This dose level may raise
concern regarding radiation-induced carcinogenesis.
To put these radiation levels in context, it has been
estimated that a coronary CTA angiogram with an
effective dose of 10 mSv has a risk of inducing a
fatal cancer in 1 in 2,000 patients (27). In this
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649regard, the American Heart Association published a
statement in 2006 in which they advised that a
10-mSv threshold should not be exceeded. More-
over, submillisievert exposure was recently reached
with the latest scanner generation (28), suggesting a
potential extensive and safer use of this technique in
association with a nonradiation diagnostic tool such
as ex-ECG for risk stratiﬁcation. Third, the risk
of nephrotoxicity in patients with normal renal
function is negligible. Indeed, no cases of renal
failure were observed in our population.
The results of our study suggest that patients with
suspected CAD may be divided into 3 groups with
different management and follow-up strategies: 1)
patients with normal coronary anatomy in which
short- or mid-term follow-up is not required; 2) pa-
tients without ﬂow-limiting coronary atherosclerosis
in whom drug treatment, aggressive risk factor
modiﬁcation, and mid-term follow-up with frequent
ex-ECG are needed; and 3) patients with ﬂow-
limiting stenoses in whom further short-term evalu-
ation with functional stress testing is highly advisable
to assess the need and choose the type of myocardial
revascularization. However, this proposed clinical
strategy needs to be evaluated in a dedicated multi-
center study.Study limitations. First, thiswas a single-center study.
A second limitation was the limited number of hard
cardiac events due to the stable condition of our pop-
ulation. Third, in the ex-ECG prognostic evaluation,
we did not emphasize the role of nonelectrocardio-
graphic parameters such as functional capacity,
chronotropic response, heart rate recovery, and
ventricular ectopy, which may add further prognostic
information beyond that provided by ST-segment
changes. However, these parameters are rarely used
in clinical practice for clinical decision making.
CONCLUS IONS
CTA may show a higher prognostic value compared
with ex-ECG in patients with suspected CAD,
mainly in those with a low to intermediate pre-test
likelihood of CAD. In this clinical setting, CTA
may be a better diagnostic tool and may play a key
role in prognostic stratiﬁcation in a combined
anatomic and functional assessment workﬂow.
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